In adults with overweight or obesity and CVD, but without diabetes, semaglutide reduced MACE at a mean 40 mo. Koutroumpakis E, Deswal A. Ann Intern Med 2024 Mar 5. doi: 10.7326/J24-0008.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Koutroumpakis E, Deswal A. In adults with overweight or obesity and CVD, but without diabetes, semaglutide reduced MACE at a mean 40 mo. Ann Intern Med 2024 Mar 5. doi: 10.7326/J24-0008.
PMID: 38437690